185 related articles for article (PubMed ID: 9777974)
61. Which is the better option: recombinant human PDGF-BB 0.01% gel or standard wound care, in diabetic neuropathic large plantar ulcers off-loaded by a customized contact cast?
Bhansali A; Venkatesh S; Dutta P; Dhillon MS; Das S; Agrawal A
Diabetes Res Clin Pract; 2009 Jan; 83(1):e13-6. PubMed ID: 19081156
[TBL] [Abstract][Full Text] [Related]
62. Clinical evaluation of recombinant human platelet-derived growth factor for the treatment of lower extremity diabetic ulcers. Diabetic Ulcer Study Group.
Steed DL
J Vasc Surg; 1995 Jan; 21(1):71-8; discussion 79-81. PubMed ID: 7823364
[TBL] [Abstract][Full Text] [Related]
63. Growth factors in clinical practice.
Köveker GB
Int J Clin Pract; 2000 Nov; 54(9):590-3. PubMed ID: 11220987
[TBL] [Abstract][Full Text] [Related]
64. Successful treatment of chronic wound in Klippel-Trenaunay syndrome with recombinant human platelet-derived growth factor-BB.
Danikas D; Theodorou SJ; Wurmser E
Plast Reconstr Surg; 2002 Jun; 109(7):2608-9. PubMed ID: 12045617
[No Abstract] [Full Text] [Related]
65. Basic fibroblast growth factor- and platelet-derived growth factor-mediated cell proliferation in B104 neuroblastoma cells: effect of ethanol on cell cycle kinetics.
Luo J; Miller MW
Brain Res; 1997 Oct; 770(1-2):139-50. PubMed ID: 9372213
[TBL] [Abstract][Full Text] [Related]
66. New treatments in ulcer healing and wound infection.
Edmonds M; Bates M; Doxford M; Gough A; Foster A
Diabetes Metab Res Rev; 2000; 16 Suppl 1():S51-4. PubMed ID: 11054889
[TBL] [Abstract][Full Text] [Related]
67. Functional properties of hyalocytes under PDGF-rich conditions.
Noda Y; Hata Y; Hisatomi T; Nakamura Y; Hirayama K; Miura M; Nakao S; Fujisawa K; Sakamoto T; Ishibashi T
Invest Ophthalmol Vis Sci; 2004 Jul; 45(7):2107-14. PubMed ID: 15223783
[TBL] [Abstract][Full Text] [Related]
68. Topical treatment of hypertensive leg ulcers with platelet-derived growth factor-BB: a randomized controlled trial.
Senet P; Vicaut E; Beneton N; Debure C; Lok C; Chosidow O
Arch Dermatol; 2011 Aug; 147(8):926-30. PubMed ID: 21482863
[TBL] [Abstract][Full Text] [Related]
69. Novel therapy to reverse the cellular effects of bisphosphonates on primary human oral fibroblasts.
Cozin M; Pinker BM; Solemani K; Zuniga JM; Dadaian SC; Cremers S; Landesberg R; Raghavan S
J Oral Maxillofac Surg; 2011 Oct; 69(10):2564-78. PubMed ID: 21807448
[TBL] [Abstract][Full Text] [Related]
70. Platelet-derived growth factor-B gene delivery sustains gingival fibroblast signal transduction.
Lin Z; Sugai JV; Jin Q; Chandler LA; Giannobile WV
J Periodontal Res; 2008 Aug; 43(4):440-9. PubMed ID: 18823454
[TBL] [Abstract][Full Text] [Related]
71. Sustained microgravity reduces intrinsic wound healing and growth factor responses in the rat.
Davidson JM; Aquino AM; Woodward SC; Wilfinger WW
FASEB J; 1999 Feb; 13(2):325-9. PubMed ID: 9973320
[TBL] [Abstract][Full Text] [Related]
72. Evidence for Rap1 in vascular smooth muscle cells. Regulation of their expression by platelet-derived growth factor BB.
Quarck R; Bryckaert M; Magnier C; Corvazier E; Bredoux R; de Gunzburg J; Fontenay M; Tobelem G; Enouf J
FEBS Lett; 1994 Apr; 342(2):159-64. PubMed ID: 8143870
[TBL] [Abstract][Full Text] [Related]
73. [New developments in the treatment of diabetic foot ulcers].
Bakker K; Schaper NC
Ned Tijdschr Geneeskd; 2000 Feb; 144(9):409-12. PubMed ID: 10719543
[TBL] [Abstract][Full Text] [Related]
74. Fibronectin growth factor-binding domains are required for fibroblast survival.
Lin F; Ren XD; Pan Z; Macri L; Zong WX; Tonnesen MG; Rafailovich M; Bar-Sagi D; Clark RA
J Invest Dermatol; 2011 Jan; 131(1):84-98. PubMed ID: 20811396
[TBL] [Abstract][Full Text] [Related]
75. Differential mitogenic effects of PDGF isoforms and heparin on human vascular smooth muscle cells.
Refson JS; Schachter M; Patel MK; Wolfe JH; Sever P
Biochem Soc Trans; 1995 May; 23(2):173S. PubMed ID: 7672199
[No Abstract] [Full Text] [Related]
76. Platelet-derived growth factor accelerates gastric epithelial restoration in a rabbit cultured cell model.
Watanabe S; Wang XE; Hirose M; Oide H; Kitamura T; Miwa H; Miyazaki A; Sato N
Gastroenterology; 1996 Mar; 110(3):775-9. PubMed ID: 8608887
[TBL] [Abstract][Full Text] [Related]
77. Detection of platelet-derived growth factor (PDGF)-AA in actively healing human wounds treated with recombinant PDGF-BB and absence of PDGF in chronic nonhealing wounds.
Pierce GF; Tarpley JE; Tseng J; Bready J; Chang D; Kenney WC; Rudolph R; Robson MC; Vande Berg J; Reid P
J Clin Invest; 1995 Sep; 96(3):1336-50. PubMed ID: 7657809
[TBL] [Abstract][Full Text] [Related]
78. Periodontal regeneration in humans using recombinant human platelet-derived growth factor-BB (rhPDGF-BB) and allogenic bone.
Nevins M; Camelo M; Nevins ML; Schenk RK; Lynch SE
J Periodontol; 2003 Sep; 74(9):1282-92. PubMed ID: 14584860
[TBL] [Abstract][Full Text] [Related]
79. Platelet-derived growth factors-AA and -BB regulate collagen and collagenase gene expression differentially in human fibroblasts.
Tan EM; Qin H; Kennedy SH; Rouda S; Fox JW; Moore JH
Biochem J; 1995 Sep; 310 ( Pt 2)(Pt 2):585-8. PubMed ID: 7654198
[TBL] [Abstract][Full Text] [Related]
80. Lysophosphatidic acid modulates the regenerative responses of human gingival fibroblasts and enhances the actions of platelet-derived growth factor.
Cerutis DR; Dreyer A; Cordini F; McVaney TP; Mattson JS; Parrish LC; Romito L; Huebner GR; Jabro M
J Periodontol; 2004 Feb; 75(2):297-305. PubMed ID: 15068119
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
